Raymond James Financial Services Advisors »

Aquestive Therapeutics shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $80k 16k 4.98
2024-06-30 $40k 16k 2.60
2024-03-31 $70k 17k 4.26

More positions owned by Raymond James Financial Services Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Value Etf (VTV)
Broadcom (AVGO)
Vanguard Index Fds Total Stk Mkt (VTI)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Raymond James Financial Services Advisors

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Vanguard Group
VR Adviser
Franklin Resources
Geode Capital Management
MPM Oncology Impact Management
State Street Corporation
Blue Owl Capital Holdings
Janney Montgomery Scott
Goldman Sachs Group
Morgan Stanley
Bank of America Corporation
Essex Investment Management
Northern Trust

View all funds holding Aquestive Therapeutics